TNXP
Tonix Pharmaceuticals Holding Corp
7.60$
-1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -586.2% | -591.2% | -708.1% | -449.2% | -666.2% | -566.6% | -682.5% | -742.4% | -927.3% | -735.6% | -615.3% | -311.9% | -531.6% | |
| 30.5% | 33.4% | 48.8% | 54.6% | 18.1% | 19.2% | 20.3% | 24.2% | 14.0% | 9.1% | 8.1% | 4.6% | 7.3% | |
| 52.1% | 53.9% | 68.2% | 52.3% | 36.8% | 34.6% | 36.3% | 71.2% | 54.7% | 33.5% | 28.6% | 16.7% | 26.9% | |
| 37.4% | 9.6% | 46.9% | 218.3% | -234.8% | 248.5% | -135.1% | 371.2% | 20.7% | 107.5% | -67.6% | -33.7% | -9.4% | |
| 45.4% | 11.6% | 4.4% | 0.1% | 0.3% | 0.1% | 0.2% | 127.1% | 30.9% | 34.8% | 24.6% | 4.3% | 17.8% | |
| -20.6% | – | -4.4% | 0.1% | -0.3% | -0.1% | -0.2% | -127.1% | -31.4% | -18.9% | -24.6% | -4.3% | -14.9% | |
| -3.5% | 0.0% | 6.6% | 0.0% | 0.0% | 0.0% | -125.4% | -145.2% | -1.5% | -149.8% | 0.0% | 0.0% | -27.9% | |
| – | – | – | – | -25.0% | -27.3% | -397.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 157.3% | 1,077.4% | -8.5% | 318.2% | 1,520.4% | 3,298.0% | 2,039.2% | 550.2% | 3,045.5% | 1,097.3% | 293.8% | 247.4% | 732.1% | |
| -449.8% | 474.5% | -721.2% | -131.0% | 853.2% | 2,732.1% | 1,356.1% | -319.5% | 1,967.3% | 342.4% | -322.3% | -69.3% | 177.4% | |
| -631.7% | -602.8% | -712.4% | -449.2% | -666.5% | -566.7% | -682.8% | -869.5% | -958.2% | -770.4% | -639.9% | -316.2% | -549.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.